Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of Gelsectan for diarrhoea‐predominant irritable bowel syndrome: A randomised, crossover clinical trial
Anca Trifan, Ovidiu Burta, Nicoleta Tiucă, et al.
United European Gastroenterology Journal (2019) Vol. 7, Iss. 8, pp. 1093-1101
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
Giovanni Barbara, Maria Raffaella Barbaro, Daniele Fuschi, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 258
Diagnosis and Treatment of Irritable Bowel Syndrome
Michael Camilleri
JAMA (2021) Vol. 325, Iss. 9, pp. 865-865
Closed Access | Times Cited: 237
Cell wall hemicellulose for sustainable industrial utilization
Mirza Faisal Qaseem, Humaira Shaheen, Aimin Wu
Renewable and Sustainable Energy Reviews (2021) Vol. 144, pp. 110996-110996
Closed Access | Times Cited: 168
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
Edoardo Savarino, Fabiana Zingone, Brigida Barberio, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 6, pp. 556-584
Open Access | Times Cited: 93
Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments
Alexander C. Ford, Stephen Vanner, Purna Kashyap, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 976-994
Open Access | Times Cited: 18
Impact of Diet on Symptoms of the Irritable Bowel Syndrome
Robert E. Spiller
Nutrients (2021) Vol. 13, Iss. 2, pp. 575-575
Open Access | Times Cited: 69
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
Orsolya Inczefi, P Bacsúr, Tamás Resál, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 60
Psyllium reduces inulin-induced colonic gas production in IBS: MRI andin vitrofermentation studies
David Gunn, Zainab Sabri Abbas, Hannah C. Harris, et al.
Gut (2021) Vol. 71, Iss. 5, pp. 919-927
Open Access | Times Cited: 33
The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea
Mohammad Badran, Saif Mashaqi, David Gozal
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 12, pp. 1263-1282
Open Access | Times Cited: 33
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Esther Colomier, Joost P. Algera, Chloé Melchior
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea
Orsolya Inczefi, Hélène Eutamène, Fanny Placide, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 8, pp. 1102-1113
Open Access | Times Cited: 4
Efficacy and Safety of Chia Seed Powder, Pea Protein, and Xyloglucan in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Mariya Armova, Maria P. Nikolova, Peter V. Draganov, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 1, pp. 19-19
Open Access
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome
Giovanni Marasco, Cesare Cremon, Daniele Salvi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1830-1830
Open Access
Xyloglucan Protects the Intestinal Barrier and Reduces Bacterial Translocation in Experimental Cirrhosis: A Promising Non-Antibiotic Strategy
Ignacio Iborra, Ramón Bartolí, Alba Ard�vol, et al.
Revista Española de Enfermedades Digestivas (2025)
Closed Access
Present and Future Therapeutic Approaches to Barrier Dysfunction
Marina Fortea, Mercé Albert-Bayo, Mar Abril-Gil, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 27
(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
Marilyn Hagan, Bu Hayee, Ana Rodriguez‐Mateos
Molecules (2021) Vol. 26, Iss. 7, pp. 1843-1843
Open Access | Times Cited: 26
The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review
Giuseppe Chiarioni, Stefan‐Lucian Popa, Abdulrahman Ismaiel, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 4070-4070
Open Access | Times Cited: 9
Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
Wade Billings, Karan Mathur, Hannah Craven, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 8, pp. 1538-1553.e14
Open Access | Times Cited: 22
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
Giovanni Barbara, Maria Raffaella Barbaro, Daniele Fuschi, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 18
Belgian consensus on irritable bowel syndrome
Sébastien Kindt, H Louis, Heiko U. De Schepper, et al.
Acta Gastro Enterologica Belgica (2022) Vol. 85, Iss. 2, pp. 360-382
Open Access | Times Cited: 14
Restoration of cefixime-induced gut microbiota changes by a prebiotic blend in a mouse model
Jingyi Yuan, Song Qin, Shanliang Hu, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 13-16, pp. 5197-5209
Closed Access | Times Cited: 14
Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study
Ovidiu Burta, Claudia Iacobescu, Bogdan Mateescu, et al.
Translational Gastroenterology and Hepatology (2018) Vol. 3, pp. 72-72
Open Access | Times Cited: 23
A Review of Xyloglucan: Self-Aggregation, Hydrogel Formation, Mucoadhesion and Uses in Medical Devices
Jordi Esquena
Macromol—A Journal of Macromolecular Research (2022) Vol. 2, Iss. 4, pp. 562-590
Open Access | Times Cited: 11
Future Therapies of Hepatic Encephalopathy
Adam Buckholz, Robert S. Brown
Clinics in Liver Disease (2024) Vol. 28, Iss. 2, pp. 331-344
Closed Access | Times Cited: 2
The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults
Carmen Alonso, Mar Abril-Gil, Mercé Albert-Bayo, et al.
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2054-2076
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top